- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04588870
Pilot Clinical Study Using Pre-operative Simulation for Patients Undergoing Cochlear Implant
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypothesis: Patients undergoing pre-operative CI simulation will have improved outcomes as measured by SL, MD and audiological outcomes.
The goal of this aim is to demonstrate clinical feasibility and to collect preliminary efficacy data for using the pre-operative simulation with active feedback for CI patients. This will be achieved by prospectively using the CI simulation system and evaluating both technical and clinical audiological outcomes.
C.4.1 Pre-operative Simulation: Prior to surgery, a simulation with visualization of cochlear microstructures will be created for each patient, and the surgeon will conduct iterative virtual surgery with active feedback to determine the optimal surgical approach and cochlear implant electrode position. Based on the feedback from the simulation platform, the surgeon will determine the optimal CI electrode and surgical technique using the virtual simulation to plan the actual surgery. Post-implant feedback will be displayed to the surgeon. Once parameters (SL, MD, AID) are optimized, a surgical plan will be recorded and used during the actual surgical procedure. A surgical plan will consist of the implant type, cochleostomy site, and insertion techniques used for optimal placement. This will be added to the patient electronic medical record to be referenced immediately prior to surgery. Additionally, the simulator will save all performances with the optimized performance being made available for review on the simulator at any time (3-dimensional playback).
C.4.2 Clinical Outcomes: Aided speech perception testing in the CI ear will be administered at 6- and 12-months post activation using monosyllabic words (CNC Word test) presented at 60 dB SPL (A-weighted) as well as sentences (AzBio) in quiet and at +10 signal-to-noise ratio. Percent correct will be calculated for each test and will serve as the primary clinical outcomes.
C.4.3 User Evaluation: Simulator evaluation (user interface, usefulness, potential usage in future, and overall satisfactory) and feedback/comments from the surgeon about the simulation platform will continued to be collected pre and post-operatively to provide insight into continued future improvement of the simulation platform.
C.4.5 Reproducibility and Rigor:
Statistical Analysis: Demographic information as well as post-op CI location parameters (SL, MD, AID), pre/post-op CNC and AzBio scores will be summarized with descriptive statistics: mean/SD, median/IQR for continuous variables and count/percentage for categorical data. Changes of the CNC /AzBio scores overtime will be analyzed using linear mixed models to account for the association of measures from the same patient at different time points, and to deal with missing data assuming missing data will occur randomly. Exploratory analysis will be conducted to (1) evaluate the association of the CI location parameters with the post-op CNC scores; (2) compare the post-op CI location parameters with the CI patients without pre-op simulations that are reported in the literature and/or those who have undergone CI insertion in this institution (historical controls at OSU).
Sample Size: For this pilot study, a sample size of 30 patients is proposed to evaluate selected feasibility issues, assess the adequacy of instrumentation, and collect preliminary efficacy data (along with historical data) for the design of a larger prospective, randomized trial. For the improvement of the clinical outcome (CNC) after CI, a sample size of 30 patients produces a one-sided 90% upper confidence limit of variance <1.5 when the sample variance of the improvement of CNC is 1.0. Up to 36 patients will be enrolled to account for potential attrition due to various unexpected reasons during the period from the enrollment to implant surgery, to 6-month follow-up.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sensorineural Deafness
- Candidate for cochlear implantation
Exclusion Criteria:
- Inability to participate
- Not a candidate for cochlear implantation
- Age less than 18 or greater than 90
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Preoperative Cochlear Implant
The intervention will be the use of a surgical simulation system preoperatively by the surgeon to develop the surgical plan to optimize electrode array placement with respect to scalar location and modiolar distance.
|
Prior to surgery, the surgeon will perform virtual cochlear implant surgery on patient specific imaging data within a computer simulation program.
The surgeon will be able to iterate the procedure on the simulator until achieving the best electrode array location is achieved with respect to scalar location and modiolar distance.
A written and graphical surgical plan will then be developed that the surgeon can use in the actual surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of CNC score
Time Frame: 6 months after cochlear implantation compared to pre surgery.
|
Aided speech perception testing in the CI ear, higher percent score (up to 100) means better hearing outcome.
Range is from 0 to 100%.
|
6 months after cochlear implantation compared to pre surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AZBio scores
Time Frame: 6 months after cochlear implantation
|
Aided speech perception testing in the CI ear, higher percent score (up to 100) means better hearing outcome.
Range is from 0 to 100%.
|
6 months after cochlear implantation
|
CNC scores
Time Frame: 12 months after cochlear implantation
|
Aided speech perception testing in the CI ear, higher percent score (up to 100) means better hearing outcome.
Range is from 0 to 100%.
|
12 months after cochlear implantation
|
AZBio scores
Time Frame: 12 months after cochlear implantation
|
Aided speech perception testing in the CI ear, higher percent score (up to 100) means better hearing outcome.
Range is from 0 to 100%.
|
12 months after cochlear implantation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scalar Location
Time Frame: 1 to 4 weeks after surgery (first post op imaging)
|
location of the electrode array within the cochlear with respect to scalar
|
1 to 4 weeks after surgery (first post op imaging)
|
Modiolar Distance
Time Frame: 1 to 4 weeks after surgery (first post op imaging)
|
electrode distance from the mid-modiolar line as an approximation of the distance to the spiral ganglion nerves.
|
1 to 4 weeks after surgery (first post op imaging)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OSU2020H0080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensori-Neural Deafness
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Washington University School of MedicineCompletedNeural ConnectivityUnited States
-
Yale UniversityCompleted
-
Vanderbilt University Medical CenterNot yet recruitingInfrared Neural Stimulation (INS)United States
-
University of ConnecticutNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingNeural Bases of Speech Perception
-
University Hospital TuebingenGerman Research Foundation; Ludwig-Maximilians - University of Munich; University... and other collaboratorsCompleted
-
Hospices Civils de LyonCompleted
-
RWTH Aachen UniversityAdvanced BionicsCompletedDeafness, Bilateral | Deafness Unilateral | Deafness Congenital | Deafness, AcquiredGermany
-
Sheba Medical CenterComputational Imaging Lab , Dr. Arnaldo MayerUnknownPET Images and Deep Neural Networks AlgorithmsIsrael
-
University of BirminghamCompletedNeural Responses | Appetite Hormones | Subjective Appetite SensationsUnited Kingdom